| [1] |
Ge D, Chen H, Zheng S, et al. Hsa-miR-889-3p promotes the proliferation of osteosarcoma through inhibiting myeloid cell nuclear differentiation antigen expression[J]. Biomed Pharmacother, 2019, 114: 108819. DOI: 10.1016/j.biopha.2019.108819.
|
| [2] |
Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis[J]. Chem Biol Interact, 2018, 292: 76-83. DOI: 10.1016/j.cbi.2018.07.008.
|
| [3] |
Xu FY, Liu CW, Zhou DD, et al. TGF-β/SMAD pathways and its regulation in hepatic fibrosis[J]. J Histochem Cytochem, 2016, 64(3): 157-167. DOI: 10.1369/0022155415627681.
|
| [4] |
Wang Y, Shen RW, Han B, et al. Notch signaling mediated by TGF-β/Smad pathway in concanavalin A-induced liver fibrosis in rats[J]. World J Gastroenterol, 2017, 23(13): 2330-2336. DOI: 10.3748/wjg.v23.i13.2330.
|
| [5] |
Ran LJ, Liang J, Deng X. MicroRNAs regulate hepatic fibrosis via TGF-β/Smad pathway[J]. World Chinese Journal of Digestology, 2017, 25(2): 166. DOI: 10.11569/wcjd.v25.i2.166.
|
| [6] |
Du GF, Wang J, Zhang T, et al. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo[J]. Cell Death Dis, 2020, 11(2): 118. DOI: 10.1038/s41419-020-2229-2.
|
| [7] |
Genz B, Coleman MA, Irvine KM, et al. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells[J]. Sci Rep, 2019, 9(1): 8541. DOI: 10.1038/s41598-019-44865-1.
|
| [8] |
J Hyun, Y Jung. MicroRNAs in liver fibrosis: focusing on the interaction with hedgehog signaling[J]. World J Gastroenterol, 2016, 22 (29): 6652-6662. DOI: 10.3748/wjg.v22.i29.6652.
|
| [9] |
Wang L, Wu HL, Wu XF, et al. Mechanism of anti hepatic fibrosis of traditional chinese medicine[J]. Clinical Journal of Traditional Chinese Medicine, 2019, 31(5): 818-821. DOI: 10.16448/j.cjtcm.2019.0240.
|
| [10] |
付玲珠, 郑婷, 张永生. TGF-β/Smad信号转导通路与肝纤维化研究进展[J]. 中国临床药理学与治疗学, 2014, 19(10): 1189-1195.
|
| [11] |
Wang TX, Li Y, Chen J, et al. TGF-β1/Smad3 signaling promotes collagen synthesis in pulmonary artery smooth muscle by down-regulating miR-29b[J]. Int J Clin Exp Pathol, 2018, 11(12): 5592-5601. PMID: 31949646.
|
| [12] |
田甜, 马国珍, 廖志峰, 等. TGF-β1、PDGF、CTGF 与肝纤维化发病机制的相关性研究进展[J]. 甘肃医药, 2014, 33(10): 740-742. DOI: 10.15975/j.cnki.gsyy.2014.10.044.
|
| [13] |
Tu XL, Zhang HY, Zhang JC, et al. MicroRNA-101 suppresses liver fibrosis by targeting the TGF-β signalling pathway[J]. J Pathol, 2014, 234(1): 46-59. DOI: 10.1002/path.4373.
|
| [14] |
于洋, 史嘉翊, 黄珍, 等. 肝纤维化中TGF-β/Smad信号通路研究进展[J]. 牡丹江医学院学报, 2019, 40(5): 121-123, 174. DOI: 10.13799/j.cnki.mdjyxyxb.2019.05.038.
|
| [15] |
Derynck R, Budi EH. Specificity, versatility, and control of TGF-β family signaling[J]. Sci Signal, 2019, 12(570): eaav5183. DOI: 10.1126/scisignal.aav5183.
|
| [16] |
Kavitha N, Vijayarathna S, Jothy SL, et al. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis[J]. Asian Pac J Cancer Prev, 2014, 15(18): 7489-7497. DOI: 10.7314/apjcp.2014.15.18.7489.
|
| [17] |
Miyoshi K, Okada TN, Siomi H, et al. Characterization of the miRNA-RISC loading complex and miRNA-RISC formed in the Drosophila miRNA pathway[J]. RNA, 2009, 15(7): 1282-1291. DOI: 10.1261/rna.1541209.
|
| [18] |
Ying SY, Chang DC, Lin SL. The MicroRNA[J]. Methods Mol Biol, 2018, 1733: 1-25. DOI: 10.1007/978-1-4939-7601-0_1.
|
| [19] |
Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9): 597-610. DOI: 10.1038/nrg2843.
|
| [20] |
孙海婷. microRNA作用靶基因的预测[J]. 科技创新与应用, 2013, (23): 57-58. CNKI: SUN:CXYY.0.2013-23-045.
|
| [21] |
曾佛来, 施梅姐, 萧焕明, 等. 微小RNAs参与调控肝纤维化转化生长因子β/Smad信号通路的研究进展[J]. 广西医学, 2019, 41(15): 1962-1964, 1968. DOI: 10.11675/j.issn.0253-4304.2019.15.22.
|
| [22] |
Lakner AM, Steuerwald NM, Walling TL, et al. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis[J]. Hepatology, 2012, 56(1): 300-310. DOI: 10.1002/hep.25613.
|
| [23] |
Zhang Y, Huang XR, Wei LH, et al. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling[J]. Mol Ther, 2014, 22(5): 974-985. DOI: 10.1038/mt.2014.25.
|
| [24] |
Huang CF, Sun CC, Zhao F, et al. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis[J]. J Gastroenterol, 2015, 50(4): 480-490. DOI: 10.1007/s00535-014-0986-3.
|
| [25] |
Sun X, He Y, Ma TT, et al. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation[J]. Mol Cell Biochem, 2014, 388(1-2): 11-23. DOI: 10.1007/s11010-013-1895-0.
|
| [26] |
He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4[J]. Cell Signal, 2012, 24(10): 1923-1930. DOI: 10.1016/j.cellsig.2012.06.003.
|
| [27] |
Yu FJ, Guo Y, Chen BC, et al. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7[J]. Lab Invest, 2015, 95(7): 781-789. DOI: 10.1038/labinvest.2015.58.
|
| [28] |
Wang CQ, Xu C, Fu XL, et al. Schisandrin B suppresses liver fibrosis in rats by targeting miR-101-5p through the TGF-β signaling pathway[J]. Artif Cells Nanomed Biotechnol, 2020, 48(1): 473-478. DOI: 10.1080/21691401.2020.1717507.
|
| [29] |
Wang J, Chu ESH, Chen HY, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway[J]. Oncotarget, 2015, 6(9): 7325-7338. DOI: 10.18632/oncotarget.2621.
|
| [30] |
Liang CL, Bu SR, Fan XM. Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-β1/Smad3[J]. Cell Biochem Func, 2016, 34(5): 326-333. DOI: 10.1002/cbf.3193.
|
| [31] |
Roy S, Benz F, Cardenas DV, et al. miR-30c and miR-193 are a part of the TGF-β-dependent regulatory network controlling extracellular matrix genes in liver fibrosis[J]. J Dig Dis, 2015, 16(9): 513-524. DOI: 10.1111/1751-2980.12266.
|
| [32] |
Tu XL, Zheng XX, Li HN, et al. MicroRNA-30 protects against carbon tetrachloride-induced liver fibrosis by attenuating transforming growth factor beta signaling in hepatic stellate cells[J]. Toxicol Sci, 2015, 146(1): 157-169. DOI: 10.1093/toxsci/kfv081.
|
| [33] |
Noetel A, Kwiecinski M, Elfimova N, et al. microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis[J]. Front Physiol, 2012, 3: 49. DOI: 10.3389/fphys.2012.00049.
|
| [34] |
Tu XL, Zhang YY, Zheng XX, et al. TGF-β-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice[J]. Sci Rep, 2017, 7(1): 2957. DOI: 10.1038/s41598-017-03175-0.
|
| [35] |
Huang Q, Zhang X, Bai F, et al. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways[J]. Int Immunopharmacol, 2019, 66: 41-51. DOI: 10.1016/j.intimp.2018.11.006.
|
| [36] |
Lai SC, Iwakiri Y. Is miR-21 a potent target for liver fibrosis[J]? Hepatology, 2018, 67(6): 2082-2084. DOI: 10.1002/hep.29774.
|
| [37] |
Zhu DD, He X, Duan YN, et al. Expression of microRNA-454 in TGF-β1-stimulated hepatic stellate cells and in mouse livers infected with Schistosoma japonicum[J]. Parasit Vectors, 2014, 7: 148. DOI: 10.1186/1756-3305-7-148.
|
| [38] |
Csak T, Bala S, Lippai D, et al. MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis[J]. PLoS One, 2015, 10(6): e0129251. DOI: 10.1371/journal.pone.0129251.
|
| [39] |
Lu L, Wang JL, Lu HW, et al. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: a rat fibrosis model study[J]. Biochem Biophys Res Commun, 2015, 465(3): 387-393. DOI: 10.1016/j.bbrc.2015.08.012.
|
| [40] |
Okada H, Honda M, Campbell JS, et al. Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice[J]. Cancer Sci, 2015, 106(9): 1143-1152. DOI: 10.1111/cas.12730.
|
| [41] |
Matsuura K, De Giorgi V, Schechterly C, et al. Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C[J]. Hepatology, 2016, 64(3): 732-745. DOI: 10.1002/hep.28660.
|
| [42] |
Hu JF, Chen C, Liu QD, et al. The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis[J]. Clin Sci (Lond), 2015, 129(4): 305-317. DOI: 10.1042/CS20140012.
|
| [43] |
Roderburg C, Luedde M, Vargas Cardenas D, et al. miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis[J]. J Hepatol, 2013, 58(4): 736-742. DOI: 10.1016/j.jhep.2012.11.022.
|
| [44] |
Yang YZ, Zhao XJ, Xu HJ, et al. Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling[J]. Acta Pharmacol Sin, 2019, 40(7): 879-894. DOI: 10.1038/s41401-018-0194-4.
|
京ICP备08002354号-3
